8-K: Strive Acquires Semler Scientific in All-Stock Bitcoin Merger

Strive, Inc. will acquire Semler Scientific, Inc. in an all-stock transaction, creating a combined entity with over 10,900 Bitcoin holdings and a focus on preventative diagnostics.

Summary

• Strive, Inc. is acquiring Semler Scientific, Inc. in an all-stock transaction, as announced on September 22, 2025.
• The deal represents an approximately 210% premium for Semler Scientific stockholders, equivalent to about $90.52 per share, based on the trading price as of market close on September 19, 2025.
• Each common share of Semler Scientific will be exchanged for 21.05 Class A common shares of Strive.
• Strive recently purchased 5,816 Bitcoin for $675,000,000 at an average price of $116,047 per Bitcoin, bringing its total holdings to 5,886 Bitcoin.
• The combined company is expected to hold over 10,900 Bitcoin prior to any additional financings.
• The combined company intends to explore monetizing or distributing Semler Scientific's historically profitable diagnostics business at a future date, with a new management team and an expanded mandate in preventative diagnostics.
• Semler Scientific updated its guidance for new 510(k) FDA clearance for expanded labeling of QuantaFlo, now anticipating clearance by the end of the second quarter of 2026 at the earliest.

Sentiment

Score: 8

Explanation: The merger offers a substantial premium to Semler Scientific shareholders and creates a significant Bitcoin treasury entity with ambitious growth plans. While there's an FDA clearance delay and typical merger risks, the strategic rationale and financial benefits for Semler shareholders are strong.

Positives

• Semler Scientific stockholders are receiving a substantial premium of approximately 210%, or $90.52 per share, in the all-stock merger.
• The merger creates a combined entity with significant Bitcoin holdings, totaling over 10,900 Bitcoin, positioning it as a major corporate Bitcoin holder.
• The combined company aims to become the fastest-growing corporate Bitcoin holder, operating with a preferred equity-only leverage model to avoid debt maturity risks.
• The transaction allows Semler Scientific shareholders direct participation in Strive's innovative Bitcoin strategies.
• The merger is expected to expand Semler Scientific's medical diagnostics business into a robust preventative care and wellness platform focused on early detection of chronic disease.
• Strive Asset Management, a subsidiary of Strive, manages over $2 billion in assets, providing a strong foundation for the combined entity.

Negatives

• Semler Scientific's new 510(k) FDA clearance for expanded QuantaFlo labeling is delayed, now anticipated by the end of Q2 2026 at the earliest.
• The all-stock transaction will result in dilution for existing Strive shareholders.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• There is a risk that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized.
• The proposed transaction may divert management's attention from ongoing business operations.
• Potential adverse reactions from customers or changes to business or employee relationships could result from the merger announcement or completion.
• Changes in Strive's or Semler Scientific's share price before closing could impact the final value of the transaction.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• General economic and market conditions, interest and exchange rates, monetary policy, laws and regulations and their enforcement.
• Other factors, including unknown or unpredictable factors, also could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The combined company anticipates becoming the fastest-growing corporate Bitcoin holder, aiming to operate with a preferred equity-only leverage model. It intends to explore monetizing or distributing Semler Scientific's diagnostics business at a future date, with a new management team and an expanded mandate in preventative diagnostics. Semler Scientific expects new 510(k) FDA clearance for expanded QuantaFlo labeling by the end of the second quarter of 2026 at the earliest.

Management Comments

• "This merger cements Strive's position as a top Bitcoin treasury company, and we believe our alpha-seeking strategies and capital structure position us to outperform Bitcoin over the long run. This transaction showcases how we can grow Bitcoin holdings and Bitcoin per share at an unmatched pace in the industry to drive equity value accretion." Matt Cole, Chairman & CEO of Strive.
• "We believe this merger creates significant value for our stockholders by delivering a substantial premium and direct participation in one of the most innovative Bitcoin strategies in the public markets. Just as importantly, this merger can drive shareholder value by expanding our medical diagnostics business into a robust preventative care and wellness platform focused on early detection of chronic disease. This dual-pronged strategy fuels both financial strength and mission-driven growth opportunities for our stakeholders." Eric Semler, Executive Chairman of Semler Scientific.

Industry Context

This merger signifies a growing trend of companies integrating Bitcoin into their corporate treasury strategies, moving beyond traditional asset management. The combined entity aims to leverage its substantial Bitcoin holdings and Strive's asset management expertise to create a unique value proposition in both the digital asset and preventative diagnostics sectors. The focus on a preferred equity-only leverage model for Bitcoin acquisition differentiates it from traditional leveraged Bitcoin strategies, potentially setting a new standard in the evolving corporate Bitcoin treasury landscape.

Comparison to Industry Standards

• The combined company aims to become the "fastest growing corporate Bitcoin holder," suggesting an aggressive acquisition strategy compared to peers in the digital asset space.
• Strive positions itself as a "top Bitcoin treasury company," indicating a leadership aspiration in the corporate Bitcoin sector.
• The preferred equity-only leverage model is presented as an innovative approach to avoid debt maturity risks associated with traditional leveraged Bitcoin strategies, with the goal of outperforming Bitcoin over the long run.
• Strive Asset Management's over $2 billion in assets under management (AUM) positions it as a significant player within the asset management industry.

Management Changes

Stakeholder Impact

• **Shareholders (Semler Scientific)**: Expected to receive a significant premium (210%) and direct participation in Strive's Bitcoin strategies, leading to a favorable exit.
• **Shareholders (Strive)**: Potential for dilution due to the all-stock transaction, but also potential for increased Bitcoin holdings and strategic growth in the digital asset and preventative diagnostics sectors.
• **Employees**: Potential changes to business or employee relationships due to the merger and the intention to explore monetizing/distributing the diagnostics business.
• **Customers**: Potential for adverse reactions or changes to relationships due to the merger.
• **Management**: Strive's management and board will remain, with Semler Scientific's Executive Chairman joining the combined board, indicating continuity and strategic integration at the leadership level.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• The closing of the transaction is subject to the satisfaction of customary closing conditions.
• The combined company intends to explore monetizing or distributing Semler Scientific's diagnostics business at a future date.
• Semler Scientific anticipates new 510(k) FDA clearance for QuantaFlo by the end of Q2 2026 at the earliest.

Key Dates

Recommendation

For existing Semler Scientific shareholders, the announced acquisition by Strive at a 210% premium is a highly favorable outcome, suggesting holding shares until the merger's completion to realize the value from the all-stock exchange. For potential new investors, the opportunity to benefit from this premium is largely diminished as the market price will likely reflect the offer. The strategic rationale for the combined entity, focusing on Bitcoin treasury and preventative diagnostics, presents long-term potential but also carries integration and market risks associated with digital assets.

Keywords

Bitcoin treasury, Merger, Acquisition, Semler Scientific, Strive Inc, SMLR, ASST, Medical devices, Diagnostics, QuantaFlo, FDA clearance, Preventative care, Digital assets, Corporate governance